The management of oral lichen planus

J F Setterfield; M M Black; S J Challacombe

The management of oral lichen planus

J F Setterfield, M M Black, S J Challacombe

Research output: Contribution to journal › Literature review › peer-review

71 Citations (Scopus)

Abstract

Oral lichen planus is a relatively common inflammatory disease affecting between 0.5% and 2.2% of the population in epidemiological studies. In contrast with cutaneous lichen planus (LP), in which the clinical course is often mild and resolves within 2 years, mucosal LP tends to follow a more chronic course often punctuated by acute exacerbations. Furthermore, although distinct clinical subtypes such as reticular, atrophic, hypertrophic and erosive forms are well recognized, more than one clinical phenotype may be seen at a time. The rare association with oral neoplasia should always be considered and high-risk patients must be kept under close observation. Thus the management of this disorder will vary widely both between patients, and for individual patients, with fluctuations in disease activity. Here we discuss the therapeutic options available and review the evidence for their use.

Original language	English
Pages (from-to)	176 - 182
Number of pages	7
Journal	Clinical and Experimental Dermatology
Volume	25
Issue number	3
Publication status	Published - 2000

Cite this

@article{1566df294c0444c4953a17275a6255c6,

title = "The management of oral lichen planus",

abstract = "Oral lichen planus is a relatively common inflammatory disease affecting between 0.5% and 2.2% of the population in epidemiological studies. In contrast with cutaneous lichen planus (LP), in which the clinical course is often mild and resolves within 2 years, mucosal LP tends to follow a more chronic course often punctuated by acute exacerbations. Furthermore, although distinct clinical subtypes such as reticular, atrophic, hypertrophic and erosive forms are well recognized, more than one clinical phenotype may be seen at a time. The rare association with oral neoplasia should always be considered and high-risk patients must be kept under close observation. Thus the management of this disorder will vary widely both between patients, and for individual patients, with fluctuations in disease activity. Here we discuss the therapeutic options available and review the evidence for their use.",

author = "Setterfield, {J F} and Black, {M M} and Challacombe, {S J}",

year = "2000",

language = "English",

volume = "25",

pages = "176 -- 182",

journal = "Clinical and Experimental Dermatology",

issn = "1365-2230",

publisher = "Wiley-Blackwell",

number = "3",

}

TY - JOUR

T1 - The management of oral lichen planus

AU - Setterfield, J F

AU - Black, M M

AU - Challacombe, S J

PY - 2000

Y1 - 2000

N2 - Oral lichen planus is a relatively common inflammatory disease affecting between 0.5% and 2.2% of the population in epidemiological studies. In contrast with cutaneous lichen planus (LP), in which the clinical course is often mild and resolves within 2 years, mucosal LP tends to follow a more chronic course often punctuated by acute exacerbations. Furthermore, although distinct clinical subtypes such as reticular, atrophic, hypertrophic and erosive forms are well recognized, more than one clinical phenotype may be seen at a time. The rare association with oral neoplasia should always be considered and high-risk patients must be kept under close observation. Thus the management of this disorder will vary widely both between patients, and for individual patients, with fluctuations in disease activity. Here we discuss the therapeutic options available and review the evidence for their use.

AB - Oral lichen planus is a relatively common inflammatory disease affecting between 0.5% and 2.2% of the population in epidemiological studies. In contrast with cutaneous lichen planus (LP), in which the clinical course is often mild and resolves within 2 years, mucosal LP tends to follow a more chronic course often punctuated by acute exacerbations. Furthermore, although distinct clinical subtypes such as reticular, atrophic, hypertrophic and erosive forms are well recognized, more than one clinical phenotype may be seen at a time. The rare association with oral neoplasia should always be considered and high-risk patients must be kept under close observation. Thus the management of this disorder will vary widely both between patients, and for individual patients, with fluctuations in disease activity. Here we discuss the therapeutic options available and review the evidence for their use.

M3 - Literature review

SN - 1365-2230

VL - 25

SP - 176

EP - 182

JO - Clinical and Experimental Dermatology

JF - Clinical and Experimental Dermatology

IS - 3

ER -

The management of oral lichen planus

Abstract

Fingerprint

Cite this